{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:17:16Z","timestamp":1792063036904,"version":"4.4.0"},"reference-count":186,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-AR-007465"],"award-info":[{"award-number":["T32-AR-007465"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jaad.2018.09.055","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T13:19:57Z","timestamp":1538745597000},"page":"538-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Approaches to limit systemic antibiotic use in acne: Systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments"],"prefix":"10.1016","volume":"80","author":[{"given":"John S.","family":"Barbieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Spaccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jaad.2018.09.055_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5694\/j.1326-5377.1998.tb140250.x","article-title":"Systematic review of Propionibacterium acnes resistance to systemic antibiotics","volume":"169","author":"Cooper","year":"1998","journal-title":"Med J Aust"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib2","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/S1473-3099(15)00527-7","article-title":"Systematic review of antibiotic resistance in acne: an increasing topical and oral threat","volume":"16","author":"Walsh","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.det.2015.12.003","article-title":"The Clinical Relevance of Antibiotic Resistance: Thirteen Principles That Every Dermatologist Needs to Consider When Prescribing Antibiotic Therapy","volume":"34","author":"Del Rosso","year":"2016","journal-title":"Dermatol Clin"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2133.2001.03956.x","article-title":"Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia","volume":"144","author":"Ross","year":"2001","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2018.09.055_bib5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jaad.2015.11.025","article-title":"Staphylococcus aureus carriage rates and antibiotic resistance patterns in patients with acne vulgaris","volume":"74","author":"Delost","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2018.09.055_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.139.4.467","article-title":"Effect of antibiotics on the oropharyngeal flora in patients with acne","volume":"139","author":"Levy","year":"2003","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/archdermatol.2011.355","article-title":"Association of pharyngitis with oral antibiotic use for the treatment of acne: a cross-sectional and prospective cohort study","volume":"148","author":"Margolis","year":"2012","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2018.09.055_bib8","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archderm.141.9.1132","article-title":"Antibiotic treatment of acne may be associated with upper respiratory tract infections","volume":"141","author":"Margolis","year":"2005","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000106579","article-title":"Upper respiratory tract infection in household contacts of acne patients","volume":"215","author":"Bowe","year":"2007","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.jaad.2018.09.055_bib10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/000155502320323216","article-title":"Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle","volume":"82","author":"Mills","year":"2002","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1468-3083.2011.04351.x","article-title":"Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong","volume":"27","author":"Luk","year":"2013","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1684\/ejd.2014.2309","article-title":"Antibiotic stewardship in dermatology: limiting antibiotic use in acne","volume":"24","author":"Dreno","year":"2014","journal-title":"Eur J Dermatol EJD"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaad.2016.08.001","article-title":"Patterns of antimicrobial resistance in lesions of hidradenitis suppurativa","volume":"76","author":"Fischer","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10620-015-3828-0","article-title":"Frequent Use of Antibiotics Is Associated with Colorectal Cancer Risk: Results of a Nested Case-Control Study","volume":"61","author":"Dik","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"8","key":"10.1016\/j.jaad.2018.09.055_bib15","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1001\/jamadermatol.2017.1297","article-title":"Antibiotic Resistance in Acne Treatment","volume":"153","author":"Adler","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2018.09.055_bib16","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1038\/ajg.2010.303","article-title":"Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease","volume":"105","author":"Margolis","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jaad.2018.09.055_bib17","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/gutjnl-2016-313413","article-title":"Long-term use of antibiotics and risk of colorectal adenoma","volume":"67","author":"Cao","year":"2018","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.jaad.2018.09.055_bib18","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.291.7.827","article-title":"Antibiotic use in relation to the risk of breast cancer","volume":"291","author":"Velicer","year":"2004","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jaad.2018.09.055_bib19","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris","volume":"74","author":"Zaenglein","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"17","key":"10.1016\/j.jaad.2018.09.055_bib20","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.2016.4151","article-title":"Prevalence of inappropriate antibiotic prescriptions among us ambulatory care visits, 2010-2011","volume":"315","author":"Fleming-Dutra","year":"2016","journal-title":"JAMA"},{"issue":"1 Suppl","key":"10.1016\/j.jaad.2018.09.055_bib21","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mjd.2003.618","article-title":"Management of acne: a report from a Global Alliance to Improve Outcomes in Acne","volume":"49","author":"Gollnick","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"5 Suppl","key":"10.1016\/j.jaad.2018.09.055_bib22","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaad.2009.01.019","article-title":"New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group","volume":"60","author":"Thiboutot","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib23","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1542\/peds.2005-2022","article-title":"Expert committee recommendations for acne management","volume":"118","author":"Zaenglein","year":"2006","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.055_bib24","first-page":"391","article-title":"European recommendations on the use of oral antibiotics for acne","volume":"14","author":"Dr\u00e9no","year":"2004","journal-title":"Eur J Dermatol EJD"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2018.09.055_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2011.04374.x","article-title":"European evidence-based (S3) guidelines for the treatment of acne","volume":"26","author":"Nast","year":"2012","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.055_bib26","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jaad.2016.06.057","article-title":"Duration of oral tetracycline-class antibiotic therapy and use of topical retinoids for the treatment of acne among general practitioners (GP): A retrospective cohort study","volume":"75","author":"Barbieri","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaad.2017.04.016","article-title":"Trends in prescribing behavior of systemic agents used in the treatment of acne among dermatologists and nondermatologists: A retrospective analysis, 2004-2013","volume":"77","author":"Barbieri","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2018.09.055_bib28","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jaad.2015.01.048","article-title":"Duration of oral antibiotic therapy for the treatment of adult acne: a retrospective analysis investigating adherence to guideline recommendations and opportunities for cost-savings","volume":"72","author":"Straight","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaad.2014.02.031","article-title":"A retrospective analysis of the duration of oral antibiotic therapy for the treatment of acne among adolescents: investigating practice gaps and potential cost-savings","volume":"71","author":"Lee","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib31","first-page":"181","article-title":"Acne vulgaris related to androgens - a review","volume":"23","author":"Khondker","year":"2014","journal-title":"Mymensingh Med J MMJ"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib32","first-page":"92","article-title":"The pathophysiology of acne vulgaris in children and adolescents, Part 1","volume":"74","author":"Bergfeld","year":"2004","journal-title":"Cutis"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000364860","article-title":"Acne pathogenesis: history of concepts","volume":"229","author":"Tilles","year":"2014","journal-title":"Dermatol Basel Switz"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/jid.2014.290","article-title":"Propionibacterium acnes promotes Th17 and Th17\/Th1 responses in acne patients","volume":"135","author":"Kistowska","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.sder.2008.06.002","article-title":"Hormonal therapy for acne","volume":"27","author":"George","year":"2008","journal-title":"Semin Cutan Med Surg"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2133.1984.tb04045.x","article-title":"Oral spironolactone improves acne vulgaris and reduces sebum excretion","volume":"111","author":"Goodfellow","year":"1984","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2133.1986.tb05722.x","article-title":"Oral spironolactone: an effective treatment for acne vulgaris in women","volume":"115","author":"Muhlemann","year":"1986","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib38","first-page":"84","article-title":"Spironolactone and cimetidine in treatment of acne","volume":"68","author":"Hatwal","year":"1988","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib39","first-page":"34","article-title":"Treatment of acne vulgaris with anti androgens","volume":"56","author":"Vaswani","year":"1990","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0015-0282(16)56518-2","article-title":"Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial","volume":"61","author":"Cusan","year":"1994","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.jaad.2018.09.055_bib41","first-page":"235","article-title":"A comparative study of Diane-35 plus spironolactone and Diane-35 plus finasteride in cases of hirsutism and acne","volume":"7","author":"Kriplani","year":"2009","journal-title":"Int J Endocrinol Metab"},{"issue":"9-10","key":"10.1016\/j.jaad.2018.09.055_bib42","first-page":"455","article-title":"Role of the combination spironolactone-norgestimate-estrogen in Hirsute women with polycystic ovary syndrome","volume":"59","author":"Hagag","year":"2014","journal-title":"J Reprod Med"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib43","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/jog.12543","article-title":"Comparison of desogestrel\/ethinyl estradiol plus spironolactone versus cyproterone acetate\/ethinyl estradiol in the treatment of polycystic ovary syndrome: a randomized controlled trial","volume":"41","author":"Leelaphiwat","year":"2015","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40257-016-0245-x","article-title":"Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review","volume":"18","author":"Layton","year":"2017","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib45","first-page":"115","article-title":"Topical spironolactone inhibits dihydrotestosterone receptors in human sebaceous glands: an autoradiographic study in subjects with acne vulgaris","volume":"10","author":"Berardesca","year":"1988","journal-title":"Int J Tissue React"},{"issue":"5","key":"10.1016\/j.jaad.2018.09.055_bib46","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/1523-1747.ep12472325","article-title":"Spironolactone directly inhibits proliferation of cultured human facial sebocytes and acts antagonistically to testosterone and 5 alpha-dihydrotestosterone in\u00a0vitro","volume":"100","author":"Akamatsu","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2018.09.055_bib47","first-page":"CD000194","article-title":"Spironolactone versus placebo or in combination with steroids for hirsutism and\/or acne","author":"Brown","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib48","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1067\/mjd.2000.105557","article-title":"Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients","volume":"43","author":"Shaw","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"0","key":"10.1016\/j.jaad.2018.09.055_bib49","article-title":"Spironolactone for the treatment of acne in women, a retrospective study of 110 patients","volume":"0","author":"Charny","year":"2017","journal-title":"Int J Womens Dermatol"},{"issue":"2-3","key":"10.1016\/j.jaad.2018.09.055_bib50","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000471799","article-title":"Spironolactone for the Treatment of Acne: A 4-Year Retrospective Study","volume":"233","author":"Grandhi","year":"2017","journal-title":"Dermatol Basel Switz"},{"issue":"4","key":"10.1016\/j.jaad.2018.09.055_bib51","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1684\/ejd.2017.3062","article-title":"Adult female acne treated with spironolactone: a retrospective data review of 70 cases","volume":"27","author":"Isvy-Joubert","year":"2017","journal-title":"Eur J Dermatol EJD"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.055_bib52","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00266-006-0081-0","article-title":"Anti-androgenic therapy using oral spironolactone for acne vulgaris in Asians","volume":"30","author":"Sato","year":"2006","journal-title":"Aesthetic Plast Surg"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib53","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s40257-018-0349-6","article-title":"The Use of Hormonal Antiandrogen Therapy in Female Patients with Acne: A 10-Year Retrospective Study","volume":"19","author":"Park","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.055_bib54","first-page":"632","article-title":"Frequency of Treatment Switching for Spironolactone Compared to Oral Tetracycline-Class Antibiotics for Women With Acne: A Retrospective Cohort Study 2010-2016","volume":"17","author":"Barbieri","year":"2018","journal-title":"J Drugs Dermatol JDD"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib55","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2007.09.024","article-title":"Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone","volume":"58","author":"Krunic","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2018.09.055_bib56","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2133.1988.tb02571.x","article-title":"Tolerance of spironolactone","volume":"118","author":"Hughes","year":"1988","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2018.09.055_bib57","first-page":"540","article-title":"Disturbances in sexual differentiation of rat foetuses following spironolactone treatment","volume":"95","author":"Hecker","year":"1980","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"9","key":"10.1016\/j.jaad.2018.09.055_bib59","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/jamadermatol.2015.34","article-title":"Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne","volume":"151","author":"Plovanich","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2018.09.055_bib60","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1472-6904-11-23","article-title":"The association between drospirenone and hyperkalemia: a comparative-safety study","volume":"11","author":"Bird","year":"2011","journal-title":"BMC Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.055_bib61","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/120347540200600604","article-title":"Long-term safety of spironolactone in acne: results of an 8-year followup study","volume":"6","author":"Shaw","year":"2002","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2018.09.055_bib62","doi-asserted-by":"crossref","first-page":"e4447","DOI":"10.1136\/bmj.e4447","article-title":"Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study","volume":"345","author":"Mackenzie","year":"2012","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.055_bib63","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.canep.2013.10.004","article-title":"Spironolactone use and the risk of breast and gynecologic cancers","volume":"37","author":"Biggar","year":"2013","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib64","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/bcp.13152","article-title":"Spironolactone use and risk of incident cancers: a retrospective, matched cohort study","volume":"83","author":"Mackenzie","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-7824(94)90106-6","article-title":"New progestogens in oral contraception","volume":"49","author":"Fotherby","year":"1994","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.jaad.2018.09.055_bib66","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0010-7824(99)00093-1","article-title":"Effect of low-dose oral contraceptives on androgenic markers and acne","volume":"60","author":"Thorneycroft","year":"1999","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.jaad.2018.09.055_bib67","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0029-7844(97)00059-8","article-title":"Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial","volume":"89","author":"Redmond","year":"1997","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.jaad.2018.09.055_bib68","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/AOG.0b013e318187e1c5","article-title":"Treatment of acne using a 3-milligram drospirenone\/20-microgram ethinyl estradiol oral contraceptive administered in a 24\/4 regimen: a randomized controlled trial","volume":"112","author":"Maloney","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib69","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejogrb.2010.12.027","article-title":"Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 \u03bcg plus drospirenone 3mg administered in a 24\/4 regimen: a pooled analysis","volume":"155","author":"Koltun","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.055_bib70","first-page":"CD004425","article-title":"Combined oral contraceptive pills for treatment of acne","author":"Arowojolu","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"4 Suppl","key":"10.1016\/j.jaad.2018.09.055_bib71","first-page":"2","article-title":"The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea","volume":"69","author":"van Vloten","year":"2002","journal-title":"Cutis"},{"issue":"5","key":"10.1016\/j.jaad.2018.09.055_bib72","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/11535450-000000000-00000","article-title":"Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicentre study","volume":"30","author":"Kelly","year":"2010","journal-title":"Clin Drug Investig"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib73","first-page":"123","article-title":"Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment","volume":"74","author":"Thorneycroft lan","year":"2004","journal-title":"Cutis"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.055_bib74","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/13625187.2011.614029","article-title":"Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol in a 24\/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21\/7 regimen","volume":"16","author":"Mansour","year":"2011","journal-title":"Eur J Contracept Reprod Health Care Off J Eur Soc Contracept"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.055_bib75","first-page":"670","article-title":"Hormonal Contraceptives and Acne: A Retrospective Analysis of 2147 Patients","volume":"15","author":"Lortscher","year":"2016","journal-title":"J Drugs Dermatol JDD"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib76","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jaad.2014.03.051","article-title":"Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris","volume":"71","author":"Koo","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2018.09.055_bib77","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0010-7824(95)00074-K","article-title":"Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation","volume":"51","author":"Rosenberg","year":"1995","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib78","first-page":"CD010813","article-title":"Combined oral contraceptives: venous thrombosis","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.jaad.2018.09.055_bib79","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1701-2163(16)35084-8","article-title":"Oral contraceptives and venous thromboembolism: pill scares and public health","volume":"33","author":"Reid","year":"2011","journal-title":"J Obstet Gynaecol Can JOGC J Obstet Gynecol Can JOGC"},{"issue":"6667","key":"10.1016\/j.jaad.2018.09.055_bib81","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/bmj.298.6667.165","article-title":"Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study","volume":"298","author":"Croft","year":"1989","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.jaad.2018.09.055_bib82","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archinte.161.8.1065","article-title":"Low-dose oral contraceptive use and the risk of myocardial infarction","volume":"161","author":"Rosenberg","year":"2001","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.jaad.2018.09.055_bib83","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.fertnstert.2006.01.009","article-title":"Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation","volume":"85","author":"Merz","year":"2006","journal-title":"Fertil Steril"},{"issue":"20","key":"10.1016\/j.jaad.2018.09.055_bib84","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM198811173192004","article-title":"A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases","volume":"319","author":"Stampfer","year":"1988","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.jaad.2018.09.055_bib85","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib86","first-page":"1","article-title":"U.S. Medical Eligibility Criteria for Contraceptive Use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep"},{"issue":"9","key":"10.1016\/j.jaad.2018.09.055_bib87","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1161\/STROKEAHA.107.488395","article-title":"Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study","volume":"38","author":"MacClellan","year":"2007","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib88","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.284.1.72","article-title":"Ischemic stroke risk with oral contraceptives: A meta-analysis","volume":"284","author":"Gillum","year":"2000","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.jaad.2018.09.055_bib89","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","article-title":"Contemporary Hormonal Contraception and the Risk of Breast Cancer","volume":"377","author":"M\u00f8rch","year":"2017","journal-title":"N Engl J Med"},{"issue":"7621","key":"10.1016\/j.jaad.2018.09.055_bib90","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","article-title":"Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study","volume":"335","author":"Hannaford","year":"2007","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.jaad.2018.09.055_bib91","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.contraception.2008.06.012","article-title":"Risk of hyperkalemia in women taking ethinylestradiol\/drospirenone and other oral contraceptives","volume":"78","author":"Loughlin","year":"2008","journal-title":"Contraception"},{"issue":"8","key":"10.1016\/j.jaad.2018.09.055_bib92","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1177\/0091270006289973","article-title":"Effect of drospirenone on serum potassium and drospirenone pharmacokinetics in women with normal or impaired renal function","volume":"46","author":"Sch\u00fcrmann","year":"2006","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.055_bib93","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1365-2133.2010.10152.x","article-title":"Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study","volume":"164","author":"Lee","year":"2011","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2018.09.055_bib94","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jaad.2005.11.1061","article-title":"Low-dose isotretinoin in the treatment of acne vulgaris","volume":"54","author":"Amichai","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2018.09.055_bib95","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1468-3083.2010.03933.x","article-title":"Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission","volume":"25","author":"Borghi","year":"2011","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"issue":"4","key":"10.1016\/j.jaad.2018.09.055_bib96","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4103\/jrpp.JRPP_17_30","article-title":"Comparing the Efficacy of Low Dose and Conventional Dose of Oral Isotretinoin in Treatment of Moderate and Severe Acne Vulgaris","volume":"6","author":"Faghihi","year":"2017","journal-title":"J Res Pharm Pract"},{"issue":"12","key":"10.1016\/j.jaad.2018.09.055_bib97","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/jamadermatol.2013.6746","article-title":"High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris","volume":"149","author":"Blasiak","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2018.09.055_bib98","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/ijd.12942","article-title":"Making sense of the effects of the cumulative dose of isotretinoin in acne vulgaris","volume":"55","author":"Rademaker","year":"2016","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib99","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2133.1993.tb11849.x","article-title":"Isotretinoin for acne vulgaris--10 years later: a safe and successful treatment","volume":"129","author":"Layton","year":"1993","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib100","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/archderm.134.3.376","article-title":"Recurrence rates after the first course of isotretinoin","volume":"134","author":"White","year":"1998","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.055_bib101","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/j.1365-2133.2007.08250.x","article-title":"Isotretinoin therapy and the incidence of acne relapse: a nested case-control study","volume":"157","author":"Azoulay","year":"2007","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2018.09.055_bib102","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000246017","article-title":"Oral isotretinoin. How can we treat difficult acne patients?","volume":"195","author":"Leyden","year":"1997","journal-title":"Dermatol Basel Switz"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib103","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.det.2015.11.004","article-title":"Safety Considerations and Monitoring in Patients Treated with Systemic Medications for Acne","volume":"34","author":"Park","year":"2016","journal-title":"Dermatol Clin"},{"issue":"4","key":"10.1016\/j.jaad.2018.09.055_bib104","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1440-0960.2010.00657.x","article-title":"Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin","volume":"51","author":"Rademaker","year":"2010","journal-title":"Australas J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2018.09.055_bib105","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1067\/mjd.2001.113717","article-title":"Uses and complications of isotretinoin therapy","volume":"45","author":"Ellis","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib106","first-page":"221","article-title":"Ocular side effects of isotretinoin therapy","volume":"59","author":"Caffery","year":"1988","journal-title":"J Am Optom Assoc"},{"issue":"7","key":"10.1016\/j.jaad.2018.09.055_bib107","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/archdermatol.2012.352","article-title":"Ocular adverse effects of systemic treatment with isotretinoin","volume":"148","author":"Neudorfer","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2018.09.055_bib108","author":"Mirnezami"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib109","first-page":"33","article-title":"Isotretinoin treatment in patients with acne vulgaris: does it impact muscle strength, fatigue, and endurance?","volume":"96","author":"Y\u0131ld\u0131zg\u00f6ren","year":"2015","journal-title":"Cutis"},{"issue":"14","key":"10.1016\/j.jaad.2018.09.055_bib110","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJM198510033131401","article-title":"Retinoic acid embryopathy","volume":"313","author":"Lammer","year":"1985","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jaad.2018.09.055_bib111","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/ajg.2010.124","article-title":"Isotretinoin use and the risk of inflammatory bowel disease: a case-control study","volume":"105","author":"Crockett","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.jaad.2018.09.055_bib112","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1038\/ajg.2009.417","article-title":"Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study","volume":"104","author":"Bernstein","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib113","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/jamadermatol.2013.1344","article-title":"Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data","volume":"149","author":"Etminan","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2018.09.055_bib114","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/jid.2012.387","article-title":"Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study","volume":"133","author":"Alhusayen","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2018.09.055_bib115","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/jamadermatol.2014.1540","article-title":"Isotretinoin exposure and risk of inflammatory bowel disease","volume":"150","author":"Rashtak","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib116","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MEG.0000000000000496","article-title":"Does exposure to isotretinoin increase the risk for the development of inflammatory bowel disease? A meta-analysis","volume":"28","author":"Lee","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.055_bib117","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jaad.2016.12.028","article-title":"Isotretinoin treatment for acne and risk of depression: A systematic review and meta-analysis","volume":"76","author":"Huang","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.09.055_bib118","doi-asserted-by":"crossref","first-page":"c5812","DOI":"10.1136\/bmj.c5812","article-title":"Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study","volume":"341","author":"Sundstr\u00f6m","year":"2010","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib119","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/jid.2010.264","article-title":"Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study","volume":"131","author":"Halvorsen","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2018.09.055_bib120","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1067\/mjd.2001.117730","article-title":"An analysis of reports of depression and suicide in patients treated with isotretinoin","volume":"45","author":"Wysowski","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib121","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4088\/JCP.10r05993","article-title":"Retinoic acid and affective disorders: the evidence for an association","volume":"73","author":"Bremner","year":"2012","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib122","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jamadermatol.2015.3091","article-title":"Laboratory Monitoring During Isotretinoin Therapy for Acne: A Systematic Review and Meta-analysis","volume":"152","author":"Lee","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib123","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jaad.2016.03.019","article-title":"Standardized laboratory monitoring with use of isotretinoin in acne","volume":"75","author":"Hansen","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib124","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/jamadermatol.2015.3128","article-title":"Isotretinoin Laboratory Test Monitoring--A Call to Decrease Testing in an Era of High-Value, Cost-Conscious Care","volume":"152","author":"Shinkai","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2018.09.055_bib125","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamadermatol.2017.2077","article-title":"Isotretinoin and Timing of Procedural Interventions: A Systematic Review With Consensus Recommendations","volume":"153","author":"Spring","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2018.09.055_bib126","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/jdv.13776","article-title":"European evidence-based (S3) guideline for the treatment of acne - update 2016 - short version","volume":"30","author":"Nast","year":"2016","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"issue":"7","key":"10.1016\/j.jaad.2018.09.055_bib127","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/13543784.2017.1337745","article-title":"Anti-acne drugs in phase 1 and 2 clinical trials","volume":"26","author":"Zouboulis","year":"2017","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib128","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.12788\/J.SDER.2018.025","article-title":"Advances in Acne and Rosacea Therapy","volume":"37","author":"Stein Gold","year":"2018","journal-title":"Semin Cutan Med Surg"},{"issue":"11","key":"10.1016\/j.jaad.2018.09.055_bib129","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1038\/jid.2015.277","article-title":"Nitric Oxide-Releasing Nanoparticles Prevent Propionibacterium acnes-Induced Inflammation by Both Clearing the Organism and Inhibiting Microbial Stimulation of the Innate Immune Response","volume":"135","author":"Qin","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2018.09.055_bib130","first-page":"12","article-title":"Results of a Phase 2 Efficacy and Safety Study with SB204, an Investigational Topical Nitric Oxide-releasing Drug for the Treatment of Acne Vulgaris","volume":"9","author":"Baldwin","year":"2016","journal-title":"J Clin Aesthetic Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2018.09.055_bib131","first-page":"1496","article-title":"Results of a Phase 2, Randomized,Vehicle-Controlled Study Evaluating the Efficacy,Tolerability, and Safety of Daily or Twice Daily SB204 for the Treatment of Acne Vulgaris","volume":"15","author":"Eichenfield","year":"2016","journal-title":"J Drugs Dermatol JDD"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib132","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2133.2011.10332.x","article-title":"Cortexolone 17\u03b1-propionate 1% cream, a new potent antiandrogen for topical treatment of acne vulgaris. A pilot randomized, double-blind comparative study vs. placebo and tretinoin 0\u00b705% cream","volume":"165","author":"Trifu","year":"2011","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib133","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.det.2015.11.003","article-title":"Physical Modalities (Devices) in the Management of Acne","volume":"34","author":"Nestor","year":"2016","journal-title":"Dermatol Clin"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib134","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.clindermatol.2016.10.012","article-title":"Laser and light-based treatments of acne and acne scarring","volume":"35","author":"Alexiades","year":"2017","journal-title":"Clin Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.055_bib135","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s40257-014-0099-z","article-title":"Recent advances in acne pathogenesis: implications for therapy","volume":"15","author":"Das","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2018.09.055_bib136","article-title":"Comparison of efficacy of aminolaevulinic acid photodynamic therapy vs. adapalene gel plus oral doxycycline for treatment of moderate acne vulgaris-A simple, blind, randomized, and controlled trial","author":"Nicklas","year":"2018","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jaad.2018.09.055_bib137","first-page":"CD007917","article-title":"Light therapies for acne","volume":"9","author":"Barbaric","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib138","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0923-1811(02)00068-3","article-title":"Acne phototherapy with a high-intensity, enhanced, narrow-band, blue light source: an open study and in\u00a0vitro investigation","volume":"30","author":"Kawada","year":"2002","journal-title":"J Dermatol Sci"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib139","first-page":"156","article-title":"420 nm intense continuous light therapy for acne","volume":"6","author":"Omi","year":"2004","journal-title":"J Cosmet Laser Ther Off Publ Eur Soc Laser Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2018.09.055_bib140","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1046\/j.1365-2133.2000.03481.x","article-title":"Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris","volume":"142","author":"Papageorgiou","year":"2000","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib141","first-page":"71","article-title":"Combination blue (415 nm) and red (633 nm) LED phototherapy in the treatment of mild to severe acne vulgaris","volume":"8","author":"Goldberg","year":"2006","journal-title":"J Cosmet Laser Ther Off Publ Eur Soc Laser Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.055_bib142","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1586\/14787210.5.6.1059","article-title":"Acne vulgaris: lasers, light sources and photodynamic therapy--an update 2007","volume":"5","author":"Gold","year":"2007","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib143","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/lsm.20877","article-title":"Intense pulsed light (IPL): a review","volume":"42","author":"Babilas","year":"2010","journal-title":"Lasers Surg Med"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib144","first-page":"91","article-title":"The role of pulsed light and heat energy (LHE) in acne clearance","volume":"6","author":"Elman","year":"2004","journal-title":"J Cosmet Laser Ther Off Publ Eur Soc Laser Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib145","first-page":"52","article-title":"Effect of smooth pulsed light at 400 to 700 and 870 to 1,200 nm for acne vulgaris in Asian skin","volume":"36","author":"Kawana","year":"2010","journal-title":"Dermatol Surg Off Publ Am Soc Dermatol Surg Al"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib146","first-page":"239","article-title":"Photopneumatic therapy for the treatment of acne","volume":"8","author":"Wanitphakdeedecha","year":"2009","journal-title":"J Drugs Dermatol JDD"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.055_bib147","first-page":"676","article-title":"Treatment of facial acne papules and pustules in Korean patients using an intense pulsed light device equipped with a 530- to 750-nm filter","volume":"33","author":"Chang","year":"2007","journal-title":"Dermatol Surg Off Publ Am Soc Dermatol Surg Al"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.055_bib148","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0001-7310(07)70094-7","article-title":"[Pulsed dye laser treatment of acne. Study of clinical efficacy and mechanism of action]","volume":"98","author":"Harto","year":"2007","journal-title":"Actas Dermosifiliogr"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib149","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2133.2010.09806.x","article-title":"The pulsed-dye laser as an adjuvant treatment modality in acne vulgaris: a randomized controlled single-blinded trial","volume":"163","author":"Karsai","year":"2010","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib150","first-page":"118","article-title":"Role of the 585-nm pulsed dye laser in the treatment of acne in comparison with other topical therapeutic modalities","volume":"11","author":"Leheta","year":"2009","journal-title":"J Cosmet Laser Ther Off Publ Eur Soc Laser Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2018.09.055_bib151","first-page":"627","article-title":"Phototherapy in the treatment of acne vulgaris","volume":"7","author":"Sami","year":"2008","journal-title":"J Drugs Dermatol JDD"},{"issue":"9393","key":"10.1016\/j.jaad.2018.09.055_bib152","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(03)14629-6","article-title":"Pulsed-dye laser treatment for inflammatory acne vulgaris: randomised controlled trial","volume":"362","author":"Seaton","year":"2003","journal-title":"Lancet Lond Engl"},{"issue":"Suppl 2","key":"10.1016\/j.jaad.2018.09.055_bib153","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2133.2005.06971.x","article-title":"Cutaneous immunological activation elicited by a low-fluence pulsed dye laser","volume":"153","author":"Omi","year":"2005","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib154","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/lsm.20717","article-title":"Double-pass, low-fluence laser treatment using a large spot-size 1,450 nm laser improves acne","volume":"41","author":"Bernstein","year":"2009","journal-title":"Lasers Surg Med"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.055_bib155","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1365-2133.2011.10614.x","article-title":"Evaluation of the clinical efficacy of the 1,450 nm laser in acne vulgaris: a randomized split-face, investigator-blinded clinical trial","volume":"165","author":"Darn\u00e9","year":"2011","journal-title":"Br J Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.jaad.2018.09.055_bib156","first-page":"147","article-title":"Treatment of inflammatory facial acne vulgaris with the 1450-nm diode laser: a pilot study","volume":"30","author":"Friedman","year":"2004","journal-title":"Dermatol Surg Off Publ Am Soc Dermatol Surg Al"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib157","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jaad.2006.02.018","article-title":"The 1450-nm diode laser for facial inflammatory acne vulgaris: dose-response and 12-month follow-up study","volume":"55","author":"Jih","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib158","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0781.2009.00387.x","article-title":"Clinical effect of low-energy double-pass 1450 nm laser treatment for acne in Asians","volume":"25","author":"Noborio","year":"2009","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib159","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/lsm.10086","article-title":"Acne treatment with a 1,450 nm wavelength laser and cryogen spray cooling","volume":"31","author":"Paithankar","year":"2002","journal-title":"Lasers Surg Med"},{"issue":"7","key":"10.1016\/j.jaad.2018.09.055_bib160","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/jid.2015.89","article-title":"Acne Treatment Based on Selective Photothermolysis of Sebaceous Follicles with Topically Delivered Light-Absorbing Gold Microparticles","volume":"135","author":"Paithankar","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2018.09.055_bib162","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1001\/archderm.138.12.1584","article-title":"Acne vulgaris: a disease of Western civilization","volume":"138","author":"Cordain","year":"2002","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib163","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.clindermatol.2008.04.006","article-title":"Glycemic index, glycemic load, wellness and beauty: the state of the art","volume":"27","author":"Berra","year":"2009","journal-title":"Clin Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2018.09.055_bib164","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1600-0625.2009.00924.x","article-title":"Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris","volume":"18","author":"Melnik","year":"2009","journal-title":"Exp Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib165","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1684\/ejd.2011.1357","article-title":"Pathways to inflammation: acne pathophysiology","volume":"21","author":"Taylor","year":"2011","journal-title":"Eur J Dermatol EJD"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.055_bib166","doi-asserted-by":"crossref","first-page":"1039.e1","DOI":"10.1016\/j.jaad.2014.06.015","article-title":"Diet in dermatology: Part I. Atopic dermatitis, acne, and nonmelanoma skin cancer","volume":"71","author":"Bronsnick","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2018.09.055_bib167","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1600-0625.2009.00890.x","article-title":"New developments in our understanding of acne pathogenesis and treatment","volume":"18","author":"Kurokawa","year":"2009","journal-title":"Exp Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.055_bib168","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.clindermatol.2010.03.017","article-title":"Nutrition and acne","volume":"28","author":"Danby","year":"2010","journal-title":"Clin Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib169","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.sder.2005.04.002","article-title":"Implications for the role of diet in acne","volume":"24","author":"Cordain","year":"2005","journal-title":"Semin Cutan Med Surg"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib170","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jand.2013.11.010","article-title":"Relationships of self-reported dietary factors and perceived acne severity in a cohort of New York young adults","volume":"114","author":"Burris","year":"2014","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/j.jaad.2018.09.055_bib171","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-5945-12-13","article-title":"High glycemic load diet, milk and ice cream consumption are related to acne vulgaris in Malaysian young adults: a case control study","volume":"12","author":"Ismail","year":"2012","journal-title":"BMC Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2018.09.055_bib172","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/1403494812454235","article-title":"Mediterranean diet and familial dysmetabolism as factors influencing the development of acne","volume":"40","author":"Skroza","year":"2012","journal-title":"Scand J Public Health"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib173","first-page":"84","article-title":"The association of acne vulgaris with diet","volume":"88","author":"Veith","year":"2011","journal-title":"Cutis"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib174","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaad.2016.02.1220","article-title":"Dietary glycemic factors, insulin resistance, and adiponectin levels in acne vulgaris","volume":"75","author":"\u00c7erman","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2018.09.055_bib175","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaad.2007.06.028","article-title":"Dietary glycemic index and glucose, insulin, insulin-like growth factor-I, insulin-like growth factor binding protein 3, and leptin levels in patients with acne","volume":"57","author":"Kaymak","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2018.09.055_bib176","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3390\/nu2101060","article-title":"Effect of the glycemic index of carbohydrates on Acne vulgaris","volume":"2","author":"Reynolds","year":"2010","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib177","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jaad.2016.04.030","article-title":"Consumption of dairy in teenagers with and without acne","volume":"75","author":"LaRosa","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.09.055_bib178","first-page":"CD009436","article-title":"Complementary therapies for acne vulgaris","volume":"1","author":"Cao","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.055_bib179","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2340\/00015555-1346","article-title":"Clinical and histological effect of a low glycaemic load diet in treatment of acne vulgaris in Korean patients: a randomized, controlled trial","volume":"92","author":"Kwon","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jdermsci.2007.11.005","article-title":"The effect of a low glycemic load diet on acne vulgaris and the fatty acid composition of skin surface triglycerides","volume":"50","author":"Smith","year":"2008","journal-title":"J Dermatol Sci"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.055_bib181","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/ajcn\/86.1.107","article-title":"A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial","volume":"86","author":"Smith","year":"2007","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib182","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jaad.2007.01.046","article-title":"The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial","volume":"57","author":"Smith","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2018.09.055_bib183","first-page":"364","article-title":"Milk consumption: aggravating factor of acne and promoter of chronic diseases of Western societies","volume":"7","author":"Melnik","year":"2009","journal-title":"J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib184","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jaad.2004.09.022","article-title":"Acne and milk, the diet myth, and beyond","volume":"52","author":"Danby","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib185","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jaad.2004.08.007","article-title":"High school dietary dairy intake and teenage acne","volume":"52","author":"Adebamowo","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2018.09.055_bib186","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D377B9S0Z8","article-title":"Milk consumption and acne in adolescent girls","volume":"12","author":"Adebamowo","year":"2006","journal-title":"Dermatol Online J"},{"issue":"5","key":"10.1016\/j.jaad.2018.09.055_bib187","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jaad.2007.08.049","article-title":"Milk consumption and acne in teenaged boys","volume":"58","author":"Adebamowo","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.09.055_bib188","article-title":"Dairy intake and acne development: A meta-analysis of observational studies","author":"Aghasi","year":"2018","journal-title":"Clin Nutr Edinb Scotl"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.055_bib189","first-page":"70","article-title":"Whey protein precipitating moderate to severe acne flares in 5 teenaged athletes","volume":"90","author":"Silverberg","year":"2012","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2018.09.055_bib190","author":"Van Mol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218326719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218326719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T18:34:13Z","timestamp":1775241253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962218326719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":186,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0190962218326719"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2018.09.055","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Approaches to limit systemic antibiotic use in acne: Systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.09.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}